Skip to main content

Animations

MJFF Publications

5711 - 5720 of 9145 Results
Title
Year
  • Year
  • 2018
  • 2011
  • 2016
  • 2010
  • 2022
  • 2022
  • 2016
  • 2021
  • 2021
  • 2015
  • Summary Details
    OPEN
    Title: Bayesian latent time joint mixed‐effects model of progression in the Alzheimer's Disease Neuroimaging Initiative
    Journal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.dadm.2018.07.008
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Molecular insights into Parkinson's disease
    Journal Name: F1000 Medicine Reports
    Publisher: Faculty Opinions Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3410/m3-7
    Citation Count: 65
  • Summary Details
    OPEN
    Title: 4-amino-7-chloroquinoline derivatives for treating Parkinson’s disease: implications for drug discovery
    Journal Name: Expert Opinion on Drug Discovery
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1517/17460441.2016.1154529
    Citation Count: 19
  • High regulatability favors genetic selection in SLC18A2 , a vesicular monoamine transporter essential for life
    2010
    Summary Details
    RESTRICTED
    Title: High regulatability favors genetic selection in SLC18A2 , a vesicular monoamine transporter essential for life
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fj.09-140368
    Citation Count: 16
  • Summary Details
    OPEN
    Title: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity
    Journal Name: Neurotherapeutics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s13311-022-01199-7
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Pattern and implications of neurological examination findings in autosomal dominant Alzheimer disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.12684
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Serum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia—A Meta-Regression Analysis
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2016.00046
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.12463
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Investigating the relationship between the SNCA gene and cognitive abilities in idiopathic Parkinson’s disease using machine learning
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-021-84316-4
    Citation Count: 25
  • Summary Details
    OPEN
    Title: ER proteostasis disturbances in Parkinson's disease: novel insights
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2015.00039
    Citation Count: 32
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.